Arstasis Lands $25,500,000 Series E Funding

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    740 Bay Rd. Redwood City, CA 94063
  • Company Description
    Arstasis develops innovative vascular access devices designed to provide better solutions for arterial closure in catheterization procedures. The company has pioneered a unique approach to safely maximize patient comfort and hospital resource efficiencies by revolutionizing arterial access to improve closure.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series E
  • Proceeds Purposes
    The company will use the proceeds for working capital and the launch of its AXERA Access Device.
  • M&A Terms
  • Venture Investor

Trending on Xconomy